255 related articles for article (PubMed ID: 12884239)
1. Role of MUC1 and MUC5AC expressions as prognostic indicators in gastric carcinomas.
Wang JY; Chang CT; Hsieh JS; Lee LW; Huang TJ; Chai CY; Lin SR
J Surg Oncol; 2003 Aug; 83(4):253-60. PubMed ID: 12884239
[TBL] [Abstract][Full Text] [Related]
2. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
[TBL] [Abstract][Full Text] [Related]
3. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
4. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma.
Pinto-de-Sousa J; David L; Reis CA; Gomes R; Silva L; Pimenta A
Virchows Arch; 2002 Mar; 440(3):304-10. PubMed ID: 11889602
[TBL] [Abstract][Full Text] [Related]
5. Expression of MUC1 and MUC2 mucins in gastric carcinomas: their relationship with clinicopathologic parameters and prognosis.
Akyürek N; Akyol G; Dursun A; Yamaç D; Günel N
Pathol Res Pract; 2002; 198(10):665-74. PubMed ID: 12498221
[TBL] [Abstract][Full Text] [Related]
6. Expression and localization of MUC1, MUC2, MUC5AC and small intestinal mucin antigen in pancreatic tumors.
Yamasaki H; Ikeda S; Okajima M; Miura Y; Asahara T; Kohno N; Shimamoto F
Int J Oncol; 2004 Jan; 24(1):107-13. PubMed ID: 14654947
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of the association between the progression of pancreatic ductal lesions and the expression of MUC1, MUC2, MUC5AC, and E-cadherin.
Kigure S
Rinsho Byori; 2006 May; 54(5):447-52. PubMed ID: 16789413
[TBL] [Abstract][Full Text] [Related]
8. Combined evaluation of mucin antigen and E-cadherin expression may help select patients with gastric cancer suitable for minimally invasive therapy.
Tanaka M; Kitajima Y; Sato S; Miyazaki K
Br J Surg; 2003 Jan; 90(1):95-101. PubMed ID: 12520583
[TBL] [Abstract][Full Text] [Related]
9. The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays.
Li XH; Zheng HC; Wang ZG; Takahashi H; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(2A):1061-7. PubMed ID: 18507055
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of T antigen expression in patients with gastric carcinoma.
Chung YS; Yamashita Y; Kato Y; Nakata B; Sawada T; Sowa M
Cancer; 1996 May; 77(9):1768-73. PubMed ID: 8646672
[TBL] [Abstract][Full Text] [Related]
11. Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder.
Xiong L; Yang Z; Yang L; Liu J; Miao X
J Surg Oncol; 2012 Jan; 105(1):97-103. PubMed ID: 21815153
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer.
Ohno T; Aihara R; Kamiyama Y; Mochiki E; Asao T; Kuwano H
Eur J Cancer; 2006 Jan; 42(2):256-63. PubMed ID: 16356709
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study.
Lau SK; Weiss LM; Chu PG
Am J Clin Pathol; 2004 Jul; 122(1):61-9. PubMed ID: 15272531
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic significance of mucin phenotype in gastric cancer.
Wakatsuki K; Yamada Y; Narikiyo M; Ueno M; Takayama T; Tamaki H; Miki K; Matsumoto S; Enomoto K; Yokotani T; Nakajima Y
J Surg Oncol; 2008 Aug; 98(2):124-9. PubMed ID: 18521835
[TBL] [Abstract][Full Text] [Related]
15. [Expression of mucin MUC1 and MUC2 in colorectal carcinoma and their clinical significance].
Huang WB; Shi LH; Zhu XQ; Xu GX; Qi Q
Ai Zheng; 2002 Nov; 21(11):1231-4. PubMed ID: 12526222
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of mucin expression in gastric carcinoma.
Kocer B; Soran A; Kiyak G; Erdogan S; Eroglu A; Bozkurt B; Solak C; Cengiz O
Dig Dis Sci; 2004 Jun; 49(6):954-64. PubMed ID: 15309883
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma.
Uen YH; Lin SR; Wu CH; Hsieh JS; Lu CY; Yu FJ; Huang TJ; Wang JY
Clin Chim Acta; 2006 May; 367(1-2):55-61. PubMed ID: 16403482
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of MUC1, MUC2 and MUC5AC expressions in gastric carcinoma.
İlhan Ö; Han Ü; Önal B; Çelık SY
Turk J Gastroenterol; 2010 Dec; 21(4):345-52. PubMed ID: 21331986
[TBL] [Abstract][Full Text] [Related]
19. Regional lymph node metastasis as a predictor of peritoneal carcinomatosis in patients with Borrmann type IV gastric carcinoma.
Otsuji E; Yamaguchi T; Sawai K; Sakakura C; Okamoto K; Takahashi T
Am J Gastroenterol; 1999 Feb; 94(2):434-7. PubMed ID: 10022642
[TBL] [Abstract][Full Text] [Related]
20. Effects of Helicobacter pylori infection on mucin expression in gastric carcinoma and pericancerous tissues.
Wang RQ; Fang DC
J Gastroenterol Hepatol; 2006 Feb; 21(2):425-31. PubMed ID: 16509869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
